Investment Portfolio Update — 2026-06-12 현황
Here’s a quick wrap-up of the latest brokerage reports on our holdings. We’re seeing positive signals across the board, from L&C Bio’s inclusion in the KRX300 and Krafton’s new IP strategy to Mirae Asset Securities’ gains from investments in innovative companies.
Investment Strategy Summary — 2026-06-12
Reports on Large-Cap and Key Holdings
Mirae Asset Securities
Korea Investment & Securities has maintained its "Neutral" rating on Mirae Asset Securities, with a target price of 51,500 KRW. Key drivers include gains from investments in innovative companies linked to the SpaceX IPO and steady growth in its wealth management (WM) division. Mirae Asset Securities also secured the top spot in the June 2026 brokerage brand reputation analysis, further cementing its market influence.
Biotech and Tech Growth Stocks
L&C Bio
L&C Bio, a company specializing in human tissue regeneration medicine, has been included in the KRX300 index following the Korea Exchange’s regular index reshuffle. As the KRX300 represents 300 top-tier stocks across both the KOSPI and KOSDAQ, this inclusion is a major positive signal for supply-demand momentum and potential valuation rerating. The stock has already climbed 24.05% since its MK Signal recommendation, drawing significant market attention.
Seegene
In the June 2026 brand reputation analysis for life science service companies, Seegene solidified its No. 1 position with a 31% surge. The market continues to reflect positively on the company through these brand reputation metrics.
IT and Gaming Sector Analysis
Krafton
Krafton is shaking up its business model for the "post-Battlegrounds" era, having increased its trademark registrations by 47% over the past year. The strategy focuses on moving away from reliance on a single hit title by securing new global game intellectual properties (IP). Additionally, the company plans to host the "PNC 2026" Battlegrounds national tournament in Seoul, further strengthening its leadership in the global esports market.
Overall Investment Direction
Our current holdings are showing several encouraging signals:
Biotech Sector: L&C Bio’s inclusion in the KRX300 is expected to improve institutional demand, and with its rising brand reputation, a valuation rerating trend is taking shape.
Gaming/IT Sector: Krafton’s aggressive pursuit of new IP and expansion into the global esports market are clear signs that it is actively improving its fundamentals to move past recent sluggish performance.
Securities: Mirae Asset Securities’ profitable exits from innovative company investments and growth in its wealth management arm point to gradual earnings improvements.
We are maintaining a "Neutral/Hold" stance with a focus on current spot holdings, but it is time to pay close attention to the structural improvements at L&C Bio and Krafton. Once macroeconomic uncertainty eases, we anticipate opportunities for value recovery and profit realization.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
